These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 10647797)

  • 1. Association between minor elevations of creatine kinase-MB level and mortality in patients with acute coronary syndromes without ST-segment elevation. PURSUIT Steering Committee. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy.
    Alexander JH; Sparapani RA; Mahaffey KW; Deckers JW; Newby LK; Ohman EM; Corbalán R; Chierchia SL; Boland JB; Simoons ML; Califf RM; Topol EJ; Harrington RA
    JAMA; 2000 Jan; 283(3):347-53. PubMed ID: 10647797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of high-risk acute coronary syndromes and eligibility for glycoprotein IIb/IIIa inhibitors among patients admitted for possible myocardial ischemia.
    Kontos MC; Ornato JP; Schmidt KL; Tatum JL; Jesse RL
    Am Heart J; 2002 Jan; 143(1):70-5. PubMed ID: 11773914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic implication of creatine kinase elevation following elective coronary artery interventions.
    Kong TQ; Davidson CJ; Meyers SN; Tauke JT; Parker MA; Bonow RO
    JAMA; 1997 Feb; 277(6):461-6. PubMed ID: 9020269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minor myocardial damage and prognosis: are spontaneous and percutaneous coronary intervention-related events different?
    Akkerhuis KM; Alexander JH; Tardiff BE; Boersma E; Harrington RA; Lincoff AM; Simoons ML
    Circulation; 2002 Feb; 105(5):554-6. PubMed ID: 11827918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention. IMPACT-II Investigators. Integrilin (eptifibatide) to Minimize Platelet Aggregation and Coronary Thrombosis-II.
    Tardiff BE; Califf RM; Tcheng JE; Lincoff AM; Sigmon KN; Harrington RA; Mahaffey KW; Ohman EM; Teirstein PS; Blankenship JC; Kitt MM; Topol EJ
    J Am Coll Cardiol; 1999 Jan; 33(1):88-96. PubMed ID: 9935014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated creatine kinase-MB with normal creatine kinase predicts worse outcomes in patients with acute coronary syndromes: results from 4 large clinical trials.
    Galla JM; Mahaffey KW; Sapp SK; Alexander JH; Roe MT; Ohman EM; Granger CB; Armstrong PW; Harrington RA; White HD; Simoons ML; Newby LK; Califf RM; Topol EJ
    Am Heart J; 2006 Jan; 151(1):16-24. PubMed ID: 16368286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic value of creatine kinase elevations extends across the whole spectrum of acute coronary syndromes.
    Savonitto S; Granger CB; Ardissino D; Gardner L; Cavallini C; Galvani M; Ottani F; White HD; Armstrong PW; Ohman EM; Pieper KS; Califf RM; Topol EJ;
    J Am Coll Cardiol; 2002 Jan; 39(1):22-9. PubMed ID: 11755282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment modalities of non-ST-elevation acute coronary syndromes in the real world. Results of the prospective R.OS.A.I.-2 registry.
    Registro Osservazionale Angina Instabile Investigators
    Ital Heart J; 2003 Nov; 4(11):782-90. PubMed ID: 14699708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of postpercutaneous coronary intervention creatine kinase-MB and troponin I elevation in predicting mid-term mortality.
    Kini AS; Lee P; Marmur JD; Agarwal A; Duffy ME; Kim MC; Sharma SK
    Am J Cardiol; 2004 Jan; 93(1):18-23. PubMed ID: 14697460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic importance of creatine kinase and creatine kinase-MB after primary percutaneous coronary intervention for ST-elevation myocardial infarction.
    Nienhuis MB; Ottervanger JP; de Boer MJ; Dambrink JH; Hoorntje JC; Gosselink AT; Suryapranata H; van't Hof AW;
    Am Heart J; 2008 Apr; 155(4):673-9. PubMed ID: 18371475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of creatine kinase-myocardial band release to Thrombolysis in Myocardial Infarction perfusion grade after intracoronary stent placement: an ESPRIT substudy.
    Gibson CM; Murphy SA; Marble SJ; Cohen DJ; Cohen EA; Lui HK; Young J; Kitt MM; Lorenz TJ; Tcheng JE
    Am Heart J; 2002 Jan; 143(1):106-10. PubMed ID: 11773919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of creatine kinase-MB elevation after percutaneous coronary intervention in patients with chronic renal dysfunction.
    Jeremias A; Albirini A; Ziada KM; Chew DP; Brener SJ; Topol EJ; Ellis SG
    Am Heart J; 2002 Jun; 143(6):1040-5. PubMed ID: 12075261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators.
    Boersma E; Pieper KS; Steyerberg EW; Wilcox RG; Chang WC; Lee KL; Akkerhuis KM; Harrington RA; Deckers JW; Armstrong PW; Lincoff AM; Califf RM; Topol EJ; Simoons ML
    Circulation; 2000 Jun; 101(22):2557-67. PubMed ID: 10840005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, placebo-controlled trial of early eptifibatide for non-ST-segment elevation acute coronary syndromes.
    Roe MT; Christenson RH; Ohman EM; Bahr R; Fesmire FM; Storrow A; Mollod M; Peacock WF; Rosenblatt JA; Yang H; Fraulo ES; Hoekstra JW; Gibler WB; ;
    Am Heart J; 2003 Dec; 146(6):993-8. PubMed ID: 14660990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the prognosis of spontaneous and percutaneous coronary intervention-related myocardial infarction.
    Leonardi S; Thomas L; Neely ML; Tricoci P; Lopes RD; White HD; Armstrong PW; Giugliano RP; Antman EM; Califf RM; Newby LK; Mahaffey KW
    J Am Coll Cardiol; 2012 Dec; 60(22):2296-304. PubMed ID: 23122801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term clinical events following creatine kinase--myocardial band isoenzyme elevation after successful coronary stenting.
    Saucedo JF; Mehran R; Dangas G; Hong MK; Lansky A; Kent KM; Satler LF; Pichard AD; Stone GW; Leon MB
    J Am Coll Cardiol; 2000 Apr; 35(5):1134-41. PubMed ID: 10758952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Creatine kinase-MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromes.
    Roe MT; Mahaffey KW; Kilaru R; Alexander JH; Akkerhuis KM; Simoons ML; Harrington RA; Tardiff BE; Granger CB; Ohman EM; Moliterno DJ; Lincoff AM; Armstrong PW; Van de Werf F; Califf RM; Topol EJ
    Eur Heart J; 2004 Feb; 25(4):313-21. PubMed ID: 14984920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cigarette smoking status and outcome among patients with acute coronary syndromes without persistent ST-segment elevation: effect of inhibition of platelet glycoprotein IIb/IIIa with eptifibatide. The PURSUIT trial investigators.
    Hasdai D; Holmes DR; Criger DA; Topol EJ; Califf RM; Wilcox RG; Paolasso E; Simoons M; Deckers J; Harrington RA
    Am Heart J; 2000 Mar; 139(3):454-60. PubMed ID: 10689260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic value of serum myoglobin in patients with non-ST-segment elevation acute coronary syndromes. Results from the TIMI 11B and TACTICS-TIMI 18 studies.
    de Lemos JA; Morrow DA; Gibson CM; Murphy SA; Sabatine MS; Rifai N; McCabe CH; Antman EM; Cannon CP; Braunwald E
    J Am Coll Cardiol; 2002 Jul; 40(2):238-44. PubMed ID: 12106926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the prognostic value of peak creatine kinase-MB and troponin levels among patients with acute myocardial infarction: a report from the Acute Coronary Treatment and Intervention Outcomes Network Registry-get with the guidelines.
    Chin CT; Wang TY; Li S; Wiviott SD; deLemos JA; Kontos MC; Peterson ED; Roe MT
    Clin Cardiol; 2012; 35(7):424-9. PubMed ID: 22434769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.